Lipogems Prospective Study
Adipose Derived Stromal Cell Transplantation as an Adjunct to Arthroscopy in Treatment of Effusion Synovitis of the Early Degenerative Knee
Sponsor: Hospital for Special Surgery, New York
Terminated
Recruitment was suspended due to the COVID pandemic and it was decided not to resume the study.
Other terminated trials from Hospital for Special Surgery, New York
- Rheumatoid Arthritis · Apr 2024
- Post Operative Pain · Phase NA · Mar 2024
- Ankle Surgery · Mar 2023
- ALS · Phase NA · Aug 2022
- ALS · Phase NA · Aug 2022
See all terminations from Hospital for Special Surgery, New York
Other Knee Osteoarthritis trials with similar outcome
Listed as NCT03922490, this PHASE4 trial focuses on Knee Osteoarthritis and remains terminated or withdrawn. Sponsored by Hospital for Special Surgery, New York, it has been updated 7 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Mar 2023 — Jul 2024 [monthly]
Terminated PHASE4
Status: Suspended → Terminated
-
Mar 2021 — Mar 2023 [monthly]
Suspended PHASE4
Status: Not Yet Recruiting → Suspended
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE4
▶ Show 2 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
-
May 2019 — Feb 2020 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital for Special Surgery, New York
For direct contact, visit the study record on ClinicalTrials.gov .